These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 2119634

  • 1. [Analysis of cytolytic activity and cell surface phenotypes of lymphokine activated killer cells stimulated with R-IL 2 and an anti-CD 3 antibody].
    Kikuchi T, Sakai H, Nakamura N, Watanabe M, Ohno T.
    No To Shinkei; 1990 Jun; 42(6):575-80. PubMed ID: 2119634
    [Abstract] [Full Text] [Related]

  • 2. [Observations on the local administration of autologous lymphokine activated killer cells and recombinant interleukin-2 in patients with malignant gliomas].
    Yoshida S, Takai N, Ono K, Saito T, Tanaka R.
    No To Shinkei; 1988 Feb; 40(2):119-25. PubMed ID: 3259433
    [Abstract] [Full Text] [Related]

  • 3. [Induction of cytotoxicity from human lymphocytes coated with bispecific antibody against human glioma cells].
    Nitta T, Ishizawa A, Ito M, Sato K, Yagita H, Kumura K.
    No Shinkei Geka; 1990 Nov; 18(11):1001-6. PubMed ID: 2247192
    [Abstract] [Full Text] [Related]

  • 4. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 5. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB, Itoh K, Balch CM.
    J Immunol; 1987 Feb 15; 138(4):1068-73. PubMed ID: 3100627
    [Abstract] [Full Text] [Related]

  • 6. Generation of lymphokine-activated killer cell activity from human thymocytes.
    Ramsdell FJ, Golub SH.
    J Immunol; 1987 Sep 01; 139(5):1446-53. PubMed ID: 2442246
    [Abstract] [Full Text] [Related]

  • 7. The role of lymphotoxin in the IL-2-driven differentiation of human lymphokine-activated T-killer (T-LAK) cells in vitro.
    Abe Y, Van Eden M, Gatanaga M, Wang FI, Brightbill HD, Granger GA, Gatanaga T.
    Lymphokine Cytokine Res; 1993 Oct 01; 12(5):279-83. PubMed ID: 8260536
    [Abstract] [Full Text] [Related]

  • 8. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL, Li JL, Vitetta ES.
    J Immunol; 1994 Mar 01; 152(5):2368-76. PubMed ID: 8133047
    [Abstract] [Full Text] [Related]

  • 9. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC.
    Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
    Teichmann JV, Ludwig WD, Thiel E.
    Nat Immun; 1992 Feb 15; 11(3):117-32. PubMed ID: 1392400
    [Abstract] [Full Text] [Related]

  • 11. Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cells.
    Koberda J, Przepiorka D, Moser RP, Grimm EE.
    Lymphokine Cytokine Res; 1994 Apr 15; 13(2):139-45. PubMed ID: 8061115
    [Abstract] [Full Text] [Related]

  • 12. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ, Yang J, Shu S, Rosenberg SA.
    J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
    Ferrini S, Miescher S, Zocchi MR, von Fliedner V, Moretta A.
    J Immunol; 1987 Feb 15; 138(4):1297-302. PubMed ID: 3100633
    [Abstract] [Full Text] [Related]

  • 14. [Infiltrative and cytolytic activities of lymphokine-activated killer (LAK) cells against a human glioma mass: ultrastructural analysis using a three-dimensional multicellular spheroid model].
    Iwasaki K.
    Nihon Geka Hokan; 1990 Jan 01; 59(1):39-54. PubMed ID: 2130768
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 16. In vivo induction of lymphokine-activated killer cells by interleukin-2 splenic artery perfusion in advanced malignancy.
    Klasa RJ, Silver HK, Kong S.
    Cancer Res; 1990 Aug 15; 50(16):4906-10. PubMed ID: 2379154
    [Abstract] [Full Text] [Related]

  • 17. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
    Savary CA, Lotzová E.
    Lymphokine Cytokine Res; 1992 Jun 15; 11(3):149-56. PubMed ID: 1391234
    [Abstract] [Full Text] [Related]

  • 18. Modulation of lymphokine release and cytolytic activities by activating peripheral blood lymphocytes via CD2.
    Valentin H, Groux H, Gelin C, Chretien I, Bernard A.
    J Immunol; 1990 Feb 01; 144(3):875-82. PubMed ID: 1967277
    [Abstract] [Full Text] [Related]

  • 19. [Isolation and expansion of glioma-infiltrating lymphocytes in vitro: an analysis of their surface phenotypes and antitumor activities].
    Sawamura Y.
    Hokkaido Igaku Zasshi; 1991 Nov 01; 66(6):868-78. PubMed ID: 1783372
    [Abstract] [Full Text] [Related]

  • 20. Augmentation of lymphokine-activated killer cell cytotoxicity by monoclonal antibodies against human small cell lung carcinoma.
    Tong AW, Lee JC, Wang RM, Ordonez G, Stone MJ.
    Cancer Res; 1989 Aug 01; 49(15):4103-8. PubMed ID: 2545333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.